Evidence map›Paper›PMID 26883919›Full record

ArticleCytotechnology2016

Establishment and characterization of a new feline mammary cancer cell line, FkMTp.

Ana Borges, Filomena Adega, Raquel Chaves

Abstract read
In one paragraph

Article in Cytotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ana BorgesLaboratory of Cytogenomics and Animal Genomics (CAG), Department of Genetics and Biotechnology (DGB), Universityof Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.
Filomena AdegaLaboratory of Cytogenomics and Animal Genomics (CAG), Department of Genetics and Biotechnology (DGB), Universityof Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.
Raquel ChavesLaboratory of Cytogenomics and Animal Genomics (CAG), Department of Genetics and Biotechnology (DGB), Universityof Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal. rchaves@utad.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies on tumours in domestic animals are believed to greatly contribute to a better understanding of similar diseases in humans. Comparative studies have shown that feline mammary carcinomas share important features with human breast cancers, including a similar biological behaviour and histological appearance. In the present study we have established and characterized at different cellular levels one feline mammary cancer cell line, FkMTp, derived from a cat mammary carcinoma. The FkMTp cell line revealed to be a promising resource and tool to study tumour microevolution and all the mechanisms and processes involved in carcinogenesis from the tumour (primary culture) to the immortalized cell line. Several assays were conducted to assess the growth behaviour, differentiated morphology, anchorage independent growth in soft agar, wound-healing invasion and migration of the cell line across time (from the primary culture until the 160th passage). FkMTp revealed increased levels of anchorage independence, migration and invasion according to the course of time as well as different numbers of ploidy. These results demonstrate and validate the in vitro tumorigenicity of the FkMTp cell line. During the cell line establishment, it was cryopreserved approximately every six passages, including the tumour primary culture, allowing now the possibility to access almost any specific momento of the tumour progression.

Indexed as

Anchorage/invasion/migrationFeline mammary carcinomaGrowth behaviourIn vitro tumorigenicityModel cell line

Identifiers

PMID26883919
PMCPMC4960199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.